These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 30248193)

  • 41. Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference.
    Walsh J; Mills S
    Ther Deliv; 2013 Jan; 4(1):21-5. PubMed ID: 23323778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.
    Lopez FL; Ernest TB; Tuleu C; Gul MO
    Expert Opin Drug Deliv; 2015; 12(11):1727-40. PubMed ID: 26165848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Novel Development of Levothyroxine Sodium Orodispersible Mini Tablets for the Treatment of Pediatrics Hypothyroidism.
    Henestrosa C; Olivera C; Flor S; Lucangioli S; Vacatello A; Ortega CA; Favier LS; Cifuente DA
    Recent Adv Drug Deliv Formul; 2023 Sep; ():. PubMed ID: 37723959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Buccal Dosage Forms: General Considerations for Pediatric Patients.
    Montero-Padilla S; Velaga S; Morales JO
    AAPS PharmSciTech; 2017 Feb; 18(2):273-282. PubMed ID: 27301872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modern pediatric formulations of the soft candies in the form of a jelly: determination of metoclopramide content and dissolution.
    Karaiskou SG; Kouskoura MG; Markopoulou CK
    Pharm Dev Technol; 2020 Jan; 25(1):20-27. PubMed ID: 31017030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups.
    Aleksovski A; Dreu R; Gašperlin M; Planinšek O
    Expert Opin Drug Deliv; 2015 Jan; 12(1):65-84. PubMed ID: 25200881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-Processed Excipients for Dispersible Tablets-Part 2: Patient Acceptability.
    Dziemidowicz K; Lopez FL; Bowles BJ; Edwards AJ; Ernest TB; Orlu M; Tuleu C
    AAPS PharmSciTech; 2018 Aug; 19(6):2646-2657. PubMed ID: 29943280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral drug delivery in personalized medicine: unmet needs and novel approaches.
    Wening K; Breitkreutz J
    Int J Pharm; 2011 Feb; 404(1-2):1-9. PubMed ID: 21070842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Taste-masking possibilities in solid dosage forms].
    Szakonyi G; Zelkó R
    Acta Pharm Hung; 2012; 82(2):81-90. PubMed ID: 22870781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Oral formulation of choice for children].
    Lajoinie A; Henin E; Kassai B
    Arch Pediatr; 2015 Aug; 22(8):877-85. PubMed ID: 26141805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Educational paper: formulation-related issues in pediatric clinical pharmacology.
    Tuleu C; Breitkreutz J
    Eur J Pediatr; 2013 Jun; 172(6):717-20. PubMed ID: 23111761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Oral films as perspective dosage form].
    Walicová V; Gajdziok J
    Ceska Slov Farm; 2016; 65(1):15-21. PubMed ID: 27118500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of pediatric drug formulations.
    Nahata MC
    Pediatrics; 1999 Sep; 104(3 Pt 2):607-9. PubMed ID: 10469800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
    Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
    Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children.
    Golhen K; Buettcher M; Kost J; Huwyler J; Pfister M
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.
    Debotton N; Dahan A
    Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Innovative Pharmaceutical Techniques for Paediatric Dosage Forms: A Systematic Review on 3D Printing, Prilling/Vibration and Microfluidic Platform.
    Racaniello GF; Silvestri T; Pistone M; D'Amico V; Arduino I; Denora N; Lopedota AA
    J Pharm Sci; 2024 Jul; 113(7):1726-1748. PubMed ID: 38582283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rat Palatability Study for Taste Assessment of Caffeine Citrate Formulation Prepared via Hot-Melt Extrusion Technology.
    Tiwari RV; Polk AN; Patil H; Ye X; Pimparade MB; Repka MA
    AAPS PharmSciTech; 2017 Feb; 18(2):341-348. PubMed ID: 26573158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.